Carregant...
Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison
This study aimed to analyze four current pathways affecting the listing and post-listing prices of new orphan drugs (ODs) in South Korea. These mechanisms were: (1) essential OD, (2) pharmacoeconomic evaluation (PE) waiver OD, (3) weighted average price OD, and (4) PE OD. We analyzed the ratio of th...
Guardat en:
| Publicat a: | Healthcare (Basel) |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000795/ https://ncbi.nlm.nih.gov/pubmed/33800373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/healthcare9030296 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|